Correlation Between MAIA Biotechnology and BioLineRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and BioLineRx, you can compare the effects of market volatilities on MAIA Biotechnology and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and BioLineRx.

Diversification Opportunities for MAIA Biotechnology and BioLineRx

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MAIA and BioLineRx is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and BioLineRx go up and down completely randomly.

Pair Corralation between MAIA Biotechnology and BioLineRx

Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 1.08 times more return on investment than BioLineRx. However, MAIA Biotechnology is 1.08 times more volatile than BioLineRx. It trades about 0.08 of its potential returns per unit of risk. BioLineRx is currently generating about -0.07 per unit of risk. If you would invest  99.00  in MAIA Biotechnology on August 24, 2024 and sell it today you would earn a total of  116.00  from holding MAIA Biotechnology or generate 117.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MAIA Biotechnology  vs.  BioLineRx

 Performance 
       Timeline  
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

MAIA Biotechnology and BioLineRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MAIA Biotechnology and BioLineRx

The main advantage of trading using opposite MAIA Biotechnology and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.
The idea behind MAIA Biotechnology and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities